Expression of the telomerase catalytic sub-unit (htert) constitutes a key step in the development of human cancer. Although htert regulation is still unclear, several studies suggest that c-myc may activate its expression. Prostate cancer is one of the most common malignancies among men in Western c
Cyclooxygenase-2 mRNA expression correlates with aromatase expression in human breast cancer
✍ Scribed by M. Salhab; G. Singh-Ranger; R. Mokbel; F. Jouhra; W.G. Jiang; K. Mokbel
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 96 KB
- Volume
- 96
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Introduction
The cyclooxygenase‐2 (COX‐2), responsible for the conversion of arachidonic acid into prostaglandin (PG) E2, is known to increase intracellular cAMP and estrogen production in malignant breast tissue. The aromatase enzyme complex is responsible for local production of estrogens in breast cancer. Increasing evidence supports a role for COX‐2 in upregulation of aromatase activity. The aim of this study was to examine the relationship between COX‐2 and aromatase mRNA expression in human breast cancer.
Methods
A total of 160 breast samples (127 tumor tissues and 33 normal tissues) were analyzed. Levels of transcription were determined using real‐time quantitative PCR. COX‐2 and aromatase mRNA expression were normalized against CK19. Levels of expression of COX‐2 were correlated with those of aromatase using Pearson's correlation method.
Results
Levels of expression of COX‐2/CK19 of both benign and malignant tissues were positively correlated with aromatase/CK19 transcript levels (correlation coefficient = +0.536, P < 0.0001). When we compared levels of expression of both genes in malignant samples only, there was a highly significant positive correlation (r = +0.611, P < 0.00001).
Conclusion
This study demonstrates a strong positive relationship between COX‐2 and aromatase mRNA expression, and lends further support to the hypothesis that COX‐2 is an upregulator of aromatase in breast tissue. J. Surg. Oncol. 2007;96:424–428. © 2007 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract The ADAMs (a disintegrin and metalloprotease) are membrane proteins containing both protease and adhesion domains and thus may be potentially important in cancer invasion and metastasis. The aim of our study was to investigate the distribution and potential clinical significance of ADAM
## Abstract Strong expression of human epidermal growth factor receptor 2 (HER‐2)/neu in breast cancer has been associated with poor prognosis. Reduced expression of p27^Kip1^, a cyclin‐dependent kinase inhibitor, correlates with poor clinical outcome in breast cancer. In this study, we provide a c
## Abstract We investigated the expression levels of human lactoferrin (Lf), a steroid hormone‐inducible gene product the expression of which is often altered during oncogenesis, and of Δ‐lactoferrin (ΔLf), its alternative isoform, which has been shown to be absent from tumor cell lines in commonly
## Abstract The chromosome region 8p12‐p22 shows frequent allelic loss in a variety of human malignancies, including breast cancer (BC). The tumor necrosis factor‐related apoptosis‐inducing ligand (TRAIL)‐receptors TRAIL‐R1, ‐R2, ‐R3 and ‐R4 are located on 8p21‐p22 and might be candidate tumor supp